Cirrhosis
530
81
99
261
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
49 trials with published results (9%)
Research Maturity
261 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.3%
28 terminated out of 530 trials
90.3%
+3.8% vs benchmark
20%
105 trials in Phase 3/4
19%
49 of 261 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 261 completed trials
Clinical Trials (530)
Evaluation of Minimal Hepatic Encephalopathy in Patients With Cirrhosis and Portal Hypertension
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients
Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE)
TEAS for Variceal Bleeding Endoscopy in Cirrhosis
Prevalence of Pain in Hospitalized Cirrhotic Patients
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
Patient Reported Outcomes In Liver Biopsy (EUS vs. Percutaneous)
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
CirrhosisRx CDS System
Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal Disconnection
Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSD
Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LS
Volatile Organic Compounds for the Assessment of Liver Disease
Comparison of the Concentration of Estrogen and Testosterone Ratio in Male Patients With Cirrhosis and Hypotension
Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants